Smoking and risk of incident end-stage kidney disease in general population: A Nationwide Population-based Cohort Study from Korea.
Hong Sang ChoiKyung-Do HanTae Ryom OhChang Seong KimEun Hui BaeSeong Kwon MaYong-Soo KimPublished in: Scientific reports (2019)
We analyzed data from the Korean National Health Insurance Service (NHIS) to investigate whether smoking increases the risk of end-stage kidney disease (ESKD). This retrospective nationwide population-based cohort study included the data of 23,232,091 participants who underwent at least one health examination between 2009 and 2012. Smoking status was recorded at baseline. The incidence of ESKD was identified via ICD-10 codes and special medical aid codes from the Korean National Health Insurance Service database till December 2016. A Cox proportional-hazards model with multivariable adjustment was used to evaluate the association between smoking and ESKD incidence. Overall, 24.6% of participants were current smokers; 13.5% and 61.9%, were ex- and non-smokers, respectively. Overall, 45,143 cases of ESKD developed during the follow-up period. Current smokers (hazard ratio [HR], 1.39; 95% confidence interval [CI], 1.35-1.43) and ex-smokers (HR, 1.09; 95% CI, 1.06-1.12) demonstrated a significant increase in the adjusted risk of ESKD compared to non-smokers. The risk of ESKD was directly proportional to the smoking duration, number of cigarettes smoked daily, and pack-years. In conclusion, smoking is associated with a greater risk of ESKD in the general Korean population; the risk increases with an increase in the smoking duration, number of cigarettes smoked daily, and pack-years.
Keyphrases
- smoking cessation
- health insurance
- replacement therapy
- healthcare
- mental health
- risk factors
- cardiovascular disease
- public health
- electronic health record
- big data
- quality improvement
- risk assessment
- cross sectional
- machine learning
- health information
- adverse drug
- artificial intelligence
- health promotion
- human health